A Study to Evaluate the Efficacy and Safety of Perampanel Monotherapy in Untreated Participants With Focal Onset Seizures With or Without Focal to Bilateral Tonic-clonic Seizures
Clinical trial NCT05533814 · COMPLETED
Trial details
- NCT number
- NCT05533814
- Sponsor
- Eisai Korea Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-19
- Primary completion
- 2025-01-23
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.